Tìm thấy 20+ kết quả cho từ khóa "Renal cell carcinoma"
tailieu.vn Xem trực tuyến Tải xuống
EAU guidelines on renal cell carcinoma: 2014 update. Treatment of renal cell carcinoma: current status and future directions. https://doi.org/1 0.3322/caac.21411.. Clear cell renal cell carcinoma: a comparative study of histological and chromosomal characteristics between primary tumors and their corresponding metastases. doi.org/10.1007/s .
tailieu.vn Xem trực tuyến Tải xuống
FORCE dual-energy CT in pathological grading of clear cell renal cell carcinoma. https://doi.org/10.3892/ol . Papillary vs clear cell renal cell carcinoma. https://doi.org/10.1007/s . https://doi.org/10.1186/s x.. Characterization of clear cell renal cell carcinoma and other renal tumors:. Normalized dual-energy iodine ratio best differentiates renal cell carcinoma subtypes among quantitative imaging biomarkers from perfusion CT and dual-energy CT. https://doi.org/10.2214/AJR.19.22612..
tailieu.vn Xem trực tuyến Tải xuống
Liu S et al : miR-429- CRKL axis regulates clear cell renal cell carcinoma malignant progression through SOS1/MEK/ERK/MMP2/MMP9 pathway. https://doi.org/10.1016/j.biopha . Cheng R et al : miR-216b post-transcriptionally downregulates oncogene KRAS and inhibits cell proliferation and invasion in clear cell renal cell carcinoma. https://doi.org/10.3892/ijmm.2019.4328.. https://doi.org/10.1182/blood .
tailieu.vn Xem trực tuyến Tải xuống
Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension. Wagner B, Patard JJ, Mejean A, et al. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Tilki D, Nguyen HG, Dall ’ era MA, et al. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus. Parekh DJ, Cookson MS, Chapman W, et al.
tailieu.vn Xem trực tuyến Tải xuống
Bladder and Renal Cell Carcinomas. Renal Cell Carcinoma: Treatment. The prognosis of metastatic renal cell carcinoma is variable. Cohen HT, McGovern FJ: Renal-cell carcinoma. Motzer RJ et al: Sunitinib in patients with metastatic renal cell carcinoma.. Nelson EC et al: Renal cell carcinoma: Current status and emerging therapies. Winquist E et al: Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: A systematic review and meta-analysis
tailieu.vn Xem trực tuyến Tải xuống
Hypertension and risk of renal cell carcinoma among white and black Americans
tailieu.vn Xem trực tuyến Tải xuống
ionization mass spectrometry for renal cell carcinoma metabolic biomarkers discovery. Gold nanoparticles Kidney cancer biomarkers Laser desorption/ionization Mass spectrometry Renal cell carcinoma. Purpose: Renal cell carcinoma (RCC) is a very aggressive and often fatal heterogeneous disease that is usually asymptomatic until late in the disease.
tailieu.vn Xem trực tuyến Tải xuống
prediction in patients with clear cell renal cell carcinoma. Background: It is of great urgency to explore useful prognostic markers for patients with clear cell renal cell carci- noma (ccRCC). Prognostic models based on ferroptosis-related gene (FRG) in ccRCC is poorly reported for now.. We carried out least absolute shrinkage and selection operator analysis to screen out prognosis-related FRGs and constructed prognosis model for patients with ccRCC.
tailieu.vn Xem trực tuyến Tải xuống
Bladder and Renal Cell Carcinomas. Renal Cell Carcinoma. Renal cell carcinomas account for 90–95% of malignant neoplasms arising from the kidney. Notable features include resistance to cytotoxic agents, infrequent responses to biologic response modifiers such as interleukin (IL) 2, and a variable clinical course for patients with metastatic disease, including anecdotal reports of spontaneous regression..
tailieu.vn Xem trực tuyến Tải xuống
Table 1 Demographics and characteristics of patients with clear cell renal cell carcinoma (ccRCC). Time- dependent receiver operating characteristic (ROC) analysis was performed using ‘survivalROC’ package to determine the optimal cut-off values of the H-scores of HECW1. HECW1 expression is decreased in clear cell renal cell carcinoma.
tailieu.vn Xem trực tuyến Tải xuống
Clinicopathologic features of TDO2 overexpression in renal cell carcinoma. Several lines of evidence revealed that overexpression of TDO2 is involved in anoikis resistance, spheroid formation, proliferation, and invasion and correlates with poor prognosis in some cancers. The aim of this research was to uncover the expression and biofunction of TDO2 in renal cell carcinoma (RCC)..
tailieu.vn Xem trực tuyến Tải xuống
However, the specific function and clinical significance of PFKFB3 in renal cell carcinoma (RCC) are yet not clarified. This investigation assessed PFKFB3 roles in RCC.. Furthermore, a murine xeno- graft model was employed for investigating the effect of PFKFB3 on tumor growth in vivo.. Results: PFKFB3 was significantly up-regulated in RCC specimens and cell lines in comparison to normal control..
tailieu.vn Xem trực tuyến Tải xuống
Keywords: Renal cell carcinoma, CTC-WBC cluster, Circulating tumour cells, Metastasis-free survival, Prognosis. Full list of author information is available at the end of the article. Renal cell carcinoma (RCC) is a common tumour of the urinary system, accounting for 80 to 85% of all kidney tumours and 3.8% of all newly diagnosed tumours [1].. In RCC, the prognostic value of CTC-WBC clusters is not clear.
tailieu.vn Xem trực tuyến Tải xuống
Results: In the present study, we applied computational biology to identify genome-related long noncoding RNA and identified 26 novel genomic instability-associated lncRNAs in clear cell renal cell carcinoma. To further elucidate the role of the six lncRNAs in the model ’ s genome stability, we performed a gene set variation analysis (GSVA) on the matrix.
tailieu.vn Xem trực tuyến Tải xuống
Bladder and Renal Cell Carcinomas. The treatment of a tumor that has invaded muscle can be separated into control of the primary tumor and, depending on the pathologic findings at surgery, systemic chemotherapy. Radical cystectomy is the standard, although in selected cases a bladder-sparing approach is used. partial cystectomy. or a combination of resection, systemic chemotherapy, and external beam radiation therapy. In some countries, external beam radiation therapy is considered standard.
tailieu.vn Xem trực tuyến Tải xuống
The differential diagnosis of a renal mass includes cysts, benign neoplasms (adenoma, angiomyolipoma, oncocytoma), inflammatory lesions (pyelonephritis or abscesses), and other primary or metastatic cancers. Other malignancies that may involve the kidney include transitional cell carcinoma of the renal pelvis, sarcoma, lymphoma, and Wilms' tumor. All of these are less common causes of renal masses than is renal cell cancer..
tailieu.vn Xem trực tuyến Tải xuống
KIRC: Kidney renal clear cell carcinoma. EAU guidelines on renal cell carcinoma: 2014 update. https://doi.org/10.1016/j.eururo . https://doi.org/10.3322/caac.21551.. Renal cell carcinoma: diagnosis and management.
tailieu.vn Xem trực tuyến Tải xuống
Carcinoma of the Renal Pelvis and Ureter. About 2500 cases of renal pelvis and ureter cancer occur each year. nearly all are transitional cell carcinomas similar to bladder cancer in biology and appearance. This tumor is also associated with chronic phenacetin abuse and with Balkan nephropathy, a chronic interstitial nephritis endemic in Bulgaria, Greece, Bosnia-Herzegovina, and Romania..
www.scribd.com Xem trực tuyến Tải xuống
Oncocytic papillary renal cell carcinoma: A clinicopathological and genetic analysis and indolent clinical course in 14 cases. mạch thanh mảnh có chứa bọt bào, được lợp bởi một hàng tế bào u hình 7. Park B.H, Ro J.Y, Park W.S et al. Oncocytic papillary renal cell carcinoma with inverted nuclear pattern: Distinct subtype with an indolent clinical course. Mai K.T, Kohler D.M, Robertson S.J et al. Oncocytic papillary renal cell carcinoma with solid architecture: Mimic of renal oncocytoma.
tailieu.vn Xem trực tuyến Tải xuống
Cabozantinib in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience. PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUN.